Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma

被引：0
|
作者：
Omar Eton
Merrick I Ross
Mary Jo East
Paul F Mansfield
Nicholas Papadopoulos
Julie A Ellerhorst
Agop Y Bedikian
Jeffrey E Lee
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Melanoma Medical Oncology
[2] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
来源：
Journal of Translational Medicine | / 8卷
关键词：
Melanoma; Major Histocompatibility Complex Class; Adjuvant Setting; ELISPOT Assay; Autologous Tumor Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma
    Eton, Omar
    Ross, Merrick I.
    East, Mary Jo
    Mansfield, Paul F.
    Papadopoulos, Nicholas
    Ellerhorst, Julie A.
    Bedikian, Agop Y.
    Lee, Jeffrey E.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
  • [2] Vaccination with autologous heat-shock protein peptide complex-96 (HSPPC-96, Oncophage®) in metastatic melanoma.
    Parmiani, G
    Belli, F
    Testori, A
    Maio, M
    Sertoli, MR
    Andreola, G
    Gallino, G
    Piris, A
    Camerini, R
    Lewis, JJ
    Srivastava, PK
    Rivoltini, L
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3814S - 3814S
  • [3] A phase I trial of heat shock protein heat shock protein-gp96 peptide complex-96 (HSPPC-96) as autologous tumor vaccine after surgery for gastric cancer
    Heike, M
    Hertkorn, C
    Reitsma, DJ
    Lehr, HA
    Simiantonaki, N
    Wölfel, T
    Junginger, T
    Dippold, WG
    Galle, PR
    Srivastava, PK
    CELL STRESS & CHAPERONES, 2000, 5 (04): : 376 - 376
  • [4] Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial
    Sampson, John H.
    Vlahovic, Gordana
    NEURO-ONCOLOGY, 2014, 16 (02) : 169 - 170
  • [5] Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial
    Bloch, Orin
    Parsa, Andrew T.
    NEURO-ONCOLOGY, 2014, 16 (05) : 758 - 759
  • [6] Distress and immune function in renal cell carcinoma patients receiving heat shock protein-peptide complex-96 (HSPPC-96) vaccine treatment
    Cohen, L
    Savary, C
    de Moor, C
    Tomasovic, SP
    Amato, RJ
    CELL STRESS & CHAPERONES, 2000, 5 (04): : 384 - 385
  • [7] Heat-shock protein-peptide complex-96 for the treatment of cancer
    Amato, Robert J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (08) : 1267 - 1273
  • [8] Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes:: Clinical and immunologic findings
    Belli, F
    Testori, A
    Rivoltini, L
    Maio, M
    Andreola, G
    Sertoli, MR
    Gallino, G
    Piris, A
    Cattelan, A
    Lazzari, I
    Carrabba, M
    Scita, G
    Santantonio, C
    Pilla, L
    Tragni, G
    Lombardo, C
    Arienti, F
    Marchianò, A
    Queirolo, P
    Bertolini, F
    Cova, A
    Lamaj, E
    Ascani, L
    Camerini, R
    Corsi, M
    Cascinelli, N
    Lewis, JJ
    Srivastava, P
    Parmiani, G
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4169 - 4180
  • [9] Cancer vaccine -: Antigenics -: Heat-shock protein cancer vaccine -: Antigenics, HSPPC-96, Oncophage®
    不详
    BIODRUGS, 2002, 16 (01) : 72 - 74
  • [10] A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma
    Maki, Robert G.
    Livingston, Philip O.
    Lewis, Jonathan J.
    Janetzki, Sylvia
    Klimstra, David
    DeSantis, Diann
    Srivastava, Pramod K.
    Brennan, Murray F.
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (08) : 1964 - 1972
12345